| Literature DB >> 23568260 |
Sid P Kerkar1, Anthony J Leonardi, Nicolas van Panhuys, Ling Zhang, Zhiya Yu, Joseph G Crompton, Jenny H Pan, Douglas C Palmer, Richard A Morgan, Steven A Rosenberg, Nicholas P Restifo.
Abstract
Engineering CD8⁺ T cells to deliver interleukin 12 (IL-12) to the tumor site can lead to striking improvements in the ability of adoptively transferred T cells to induce the regression of established murine cancers. We have recently shown that IL-12 triggers an acute inflammatory environment that reverses dysfunctional antigen presentation by myeloid-derived cells within tumors and leads to an increase in the infiltration of adoptively transferred antigen-specific CD8⁺ T cells. Here, we find that local delivery of IL-12 increased the expression of Fas within tumor-infiltrating macrophages, dendritic cells, and myeloid-derived suppressor cells (MDSC), and that these changes were abrogated in mice deficient in IL-12-receptor signaling. Importantly, upregulation of Fas in host mice played a critical role in the proliferation and antitumor activity of adoptively transferred IL-12-modified CD8⁺ T cells. We also observed higher percentages of myeloid-derived cell populations within tumors in Fas-deficient mice, indicating that tumor stromal destruction was dependent on the Fas death receptor. Taken together, these results describe the likely requirement for costimulatory reverse signaling through Fasl on T cells that successfully infiltrate tumors, a mechanism triggered by the induction of Fas expression on myeloid-derived cells by IL-12 and the subsequent collapse of the tumor stroma.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23568260 PMCID: PMC3702103 DOI: 10.1038/mt.2013.58
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454